CV Sciences, Inc. (CVSI)
2025-03-31 | 2024-09-30 | |||
|---|---|---|---|---|
| Product sales, net | 3,606 | 3,865 | ||
| Cost of goods sold | 1,948 | 2,087 | ||
| Gross profit | 1,658 | 1,778 | ||
| Selling, general and administrative | 2,139 | 2,090 | ||
| Research and development | 30 | 29 | ||
| Benefit from reversal of accrued payroll taxes | -522 | - | ||
| Total operating expenses | 1,647 | 2,119 | ||
| Operating income (loss) | 11 | -341 | ||
| Gain on extinguishment of debt | 38 | - | ||
| Other expense, net | -151 | -115 | ||
| Loss before income taxes | -102 | -456 | ||
| Income tax expense | 7 | - | ||
| Net income (loss) | -109 | -456 | ||
| Basic eps | - | - | ||
| Diluted eps | - | - | ||
| Basic average shares | 184,264,000 | 182,261,000 | ||
| Diluted average shares | 184,264,000 | 182,261,000 | ||